434 related articles for article (PubMed ID: 33809462)
1. Anticancer Mechanism of Curcumin on Human Glioblastoma.
Wong SC; Kamarudin MNA; Naidu R
Nutrients; 2021 Mar; 13(3):. PubMed ID: 33809462
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Potential of Curcumin in the Treatment of Glioblastoma Multiforme.
Shahcheraghi SH; Zangui M; Lotfi M; Ghayour-Mobarhan M; Ghorbani A; Jaliani HZ; Sadeghnia HR; Sahebkar A
Curr Pharm Des; 2019; 25(3):333-342. PubMed ID: 30864499
[TBL] [Abstract][Full Text] [Related]
3. Prospective of curcumin, a pleiotropic signalling molecule from Curcuma longa in the treatment of Glioblastoma.
Luthra PM; Lal N
Eur J Med Chem; 2016 Feb; 109():23-35. PubMed ID: 26748069
[TBL] [Abstract][Full Text] [Related]
4. Antitumor Activity of Curcumin in Glioblastoma.
Walker BC; Mittal S
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322413
[TBL] [Abstract][Full Text] [Related]
5. Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and -resistant glioblastoma.
Barone TA; Burkhart CA; Safina A; Haderski G; Gurova KV; Purmal AA; Gudkov AV; Plunkett RJ
Neuro Oncol; 2017 Feb; 19(2):186-196. PubMed ID: 27370399
[TBL] [Abstract][Full Text] [Related]
6. Coupling to a glioblastoma-directed antibody potentiates antitumor activity of curcumin.
Langone P; Debata PR; Inigo Jdel R; Dolai S; Mukherjee S; Halat P; Mastroianni K; Curcio GM; Castellanos MR; Raja K; Banerjee P
Int J Cancer; 2014 Aug; 135(3):710-9. PubMed ID: 24142484
[TBL] [Abstract][Full Text] [Related]
7. Curcumin suppresses glioblastoma cell proliferation by p-AKT/mTOR pathway and increases the PTEN expression.
Wang Z; Liu F; Liao W; Yu L; Hu Z; Li M; Xia H
Arch Biochem Biophys; 2020 Aug; 689():108412. PubMed ID: 32445778
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-326 sensitizes human glioblastoma cells to curcumin via the SHH/GLI1 signaling pathway.
Yin S; Du W; Wang F; Han B; Cui Y; Yang D; Chen H; Liu D; Liu X; Zhai X; Jiang C
Cancer Biol Ther; 2018 Apr; 19(4):260-270. PubMed ID: 27819521
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Rb and mTOR signaling associates with synergistic anticancer effect of palbociclib and erlotinib in glioblastoma cells.
Liu S; Tang Y; Yuan X; Yuan D; Liu J; Li B; Li Y
Invest New Drugs; 2018 Dec; 36(6):961-969. PubMed ID: 29508248
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Potential of Curcumin for the Treatment of Brain Tumors.
Klinger NV; Mittal S
Oxid Med Cell Longev; 2016; 2016():9324085. PubMed ID: 27807473
[TBL] [Abstract][Full Text] [Related]
11. Natural products as promising targets in glioblastoma multiforme: a focus on NF-κB signaling pathway.
Soukhtanloo M; Mohtashami E; Maghrouni A; Mollazadeh H; Mousavi SH; Roshan MK; Tabatabaeizadeh SA; Hosseini A; Vahedi MM; Jalili-Nik M; Afshari AR
Pharmacol Rep; 2020 Apr; 72(2):285-295. PubMed ID: 32152926
[TBL] [Abstract][Full Text] [Related]
12. Peiminine Inhibits Glioblastoma in Vitro and in Vivo Through Cell Cycle Arrest and Autophagic Flux Blocking.
Zhao B; Shen C; Zheng Z; Wang X; Zhao W; Chen X; Peng F; Xue L; Shu M; Hou X; Wang K; Zhong C; Sun J; Wan J; Zhao S
Cell Physiol Biochem; 2018; 51(4):1566-1583. PubMed ID: 30497066
[TBL] [Abstract][Full Text] [Related]
13. NF-κB and STAT3 in glioblastoma: therapeutic targets coming of age.
Gray GK; McFarland BC; Nozell SE; Benveniste EN
Expert Rev Neurother; 2014 Nov; 14(11):1293-306. PubMed ID: 25262780
[TBL] [Abstract][Full Text] [Related]
14. Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors.
Dhandapani KM; Mahesh VB; Brann DW
J Neurochem; 2007 Jul; 102(2):522-38. PubMed ID: 17596214
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potentials of curcumin in the treatment of glioblstoma.
Shabaninejad Z; Pourhanifeh MH; Movahedpour A; Mottaghi R; Nickdasti A; Mortezapour E; Shafiee A; Hajighadimi S; Moradizarmehri S; Sadeghian M; Mousavi SM; Mirzaei H
Eur J Med Chem; 2020 Feb; 188():112040. PubMed ID: 31927312
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
[TBL] [Abstract][Full Text] [Related]
17. Combination treatment of berberine and solid lipid curcumin particles increased cell death and inhibited PI3K/Akt/mTOR pathway of human cultured glioblastoma cells more effectively than did individual treatments.
Maiti P; Plemmons A; Dunbar GL
PLoS One; 2019; 14(12):e0225660. PubMed ID: 31841506
[TBL] [Abstract][Full Text] [Related]
18. Effect of curcumin on glioblastoma cells.
Hesari A; Rezaei M; Rezaei M; Dashtiahangar M; Fathi M; Rad JG; Momeni F; Avan A; Ghasemi F
J Cell Physiol; 2019 Jul; 234(7):10281-10288. PubMed ID: 30585634
[TBL] [Abstract][Full Text] [Related]
19. Deregulated signaling pathways in glioblastoma multiforme: molecular mechanisms and therapeutic targets.
Mao H; Lebrun DG; Yang J; Zhu VF; Li M
Cancer Invest; 2012 Jan; 30(1):48-56. PubMed ID: 22236189
[TBL] [Abstract][Full Text] [Related]
20. The anti-cancer efficacy of curcumin scrutinized through core signaling pathways in glioblastoma.
Su CC; Wang MJ; Chiu TL
Int J Mol Med; 2010 Aug; 26(2):217-24. PubMed ID: 20596601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
